Vanda Pharmaceuticals' (VNDA) MAA for Fanaptum in Schizophrenia Accepted for Evaluation by EMA

Go back to Vanda Pharmaceuticals' (VNDA) MAA for Fanaptum in Schizophrenia Accepted for Evaluation by EMA
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Delayed: 9.96 +0.21 (2.15%)
Previous Close $9.75    52 Week High $18.00 
Open $9.77    52 Week Low $6.91 
Day High $10.07    P/E N/A 
Day Low $9.74    EPS $-0.67 
Volume 159,151